KLRS: Kalaris Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Kalaris Therapeutics Inc (KLRS).
$48.53M Market Cap.
KLRS Market Cap. (MRY)
KLRS Shares Outstanding (MRY)
KLRS Assets (MRY)
Total Assets
$6.16M
Total Liabilities
$56.78M
Total Investments
$0
KLRS Income (MRY)
Revenue
$0
Net Income
-$58.77M
Operating Expense
$65.44M
KLRS Cash Flow (MRY)
CF Operations
-$67.70M
CF Investing
$95.00M
CF Financing
$21.00K
KLRS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $6,162,000 (-96.77%) | $190,796,000 (-31.14%) | $277,079,000 (-3.32%) | $286,594,000 (-22.71%) |
Assets Current | $2,606,000 (-98.61%) | $187,635,000 (-22.80%) | $243,052,000 (-4.06%) | $253,348,000 (-29.88%) |
Assets Non-Current | $3,556,000 (12.50%) | $3,161,000 (-90.71%) | $34,027,000 (2.35%) | $33,246,000 (249.81%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | -$96,616,000 (-166.27%) | $145,781,000 (-35.07%) | $224,519,000 (-0.33%) | $225,266,000 (-36.20%) |
Property Plant & Equipment Net | $0 (0%) | $2,187,000 (-93.28%) | $32,563,000 (4.06%) | $31,292,000 (229.25%) |
Cash & Equivalents | $1,639,000 (-98.20%) | $90,973,000 (-14.93%) | $106,944,000 (-47.19%) | $202,513,000 (65.10%) |
Accumulated Other Comprehensive Income | $0 (0%) | -$62,000 (86.75%) | -$468,000 (-201.94%) | -$155,000 (-38.39%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $93,822,000 (-26.53%) | $127,703,000 (174.87%) | $46,459,000 (-80.12%) |
Investments Current | $0 (0%) | $93,822,000 (-26.53%) | $127,703,000 (174.87%) | $46,459,000 (-80.12%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $1,560,000 (-79.20%) | $7,500,000 (145.10%) | $3,060,000 (-69.71%) | $10,103,000 (558.18%) |
Accumulated Retained Earnings (Deficit) | -$116,561,000 (82.24%) | -$656,193,000 (-40.88%) | -$465,775,000 (-56.79%) | -$297,065,000 (-137.46%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $128,000 (-87.29%) | $1,007,000 (0%) |
Total Debt | $19,541,000 (-28.76%) | $27,429,000 (-22.49%) | $35,387,000 (17.70%) | $30,066,000 (245.90%) |
Debt Current | $19,541,000 (81.25%) | $10,781,000 (50.47%) | $7,165,000 (8.71%) | $6,591,000 (104.12%) |
Debt Non-Current | $0 (0%) | $16,648,000 (-41.01%) | $28,222,000 (20.22%) | $23,475,000 (329.71%) |
Total Liabilities | $56,779,000 (26.13%) | $45,015,000 (-14.36%) | $52,560,000 (-14.30%) | $61,328,000 (245.37%) |
Liabilities Current | $24,703,000 (-12.92%) | $28,367,000 (16.55%) | $24,338,000 (-35.70%) | $37,853,000 (207.90%) |
Liabilities Non-Current | $32,076,000 (92.67%) | $16,648,000 (-41.01%) | $28,222,000 (20.22%) | $23,475,000 (329.71%) |
KLRS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $42,916,000 (-11.08%) | $48,261,000 (-7.78%) | $52,332,000 (6.62%) | $49,083,000 (126.75%) |
Research & Development Expense | $12,340,000 (-90.73%) | $133,070,000 (11.95%) | $118,870,000 (-1.54%) | $120,735,000 (143.11%) |
Operating Expenses | $65,441,000 (-67.26%) | $199,901,000 (16.76%) | $171,202,000 (0.81%) | $169,818,000 (138.14%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | -$126,000 (52.45%) | -$265,000 (-126.32%) | $1,007,000 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$58,769,000 (69.14%) | -$190,418,000 (-12.87%) | -$168,710,000 (1.89%) | -$171,962,000 (-146.42%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$58,769,000 (69.14%) | -$190,418,000 (-12.87%) | -$168,710,000 (1.89%) | -$171,962,000 (-146.42%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$58,769,000 (69.14%) | -$190,418,000 (-12.87%) | -$168,710,000 (1.89%) | -$171,962,000 (-146.42%) |
Weighted Average Shares | $5,008,449 (10.70%) | $4,524,226 (35.75%) | $3,332,820 (22.10%) | $2,729,658 (133.41%) |
Weighted Average Shares Diluted | $5,008,449 (10.70%) | $4,524,226 (35.75%) | $3,332,820 (22.10%) | $2,729,658 (133.41%) |
Earning Before Interest & Taxes (EBIT) | -$58,769,000 (69.16%) | -$190,544,000 (-12.76%) | -$168,975,000 (1.16%) | -$170,955,000 (-144.98%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$65,441,000 (67.26%) | -$199,901,000 (-16.76%) | -$171,202,000 (-0.81%) | -$169,818,000 (-138.14%) |
KLRS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $95,000,000 (150.10%) | $37,985,000 (147.20%) | -$80,478,000 (-143.27%) | $185,983,000 (209.73%) |
Net Cash Flow from Financing | $21,000 (-99.97%) | $70,495,000 (-44.48%) | $126,961,000 (54624.57%) | $232,000 (-99.92%) |
Net Cash Flow from Operations | -$67,705,000 (45.60%) | -$124,451,000 (12.39%) | -$142,052,000 (-33.61%) | -$106,319,000 (-74.84%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $27,316,000 (271.04%) | -$15,971,000 (83.29%) | -$95,569,000 (-219.68%) | $79,852,000 (29.68%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $95,000,000 (150.10%) | $37,985,000 (147.20%) | -$80,478,000 (-143.27%) | $186,009,000 (209.89%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | -$26,000 (88.94%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $21,000 (-99.97%) | $70,495,000 (-44.48%) | $126,961,000 (54624.57%) | $232,000 (-99.92%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | -$44,000 (51.11%) |
Share Based Compensation | $26,347,000 (-35.39%) | $40,779,000 (-1.30%) | $41,315,000 (-6.05%) | $43,975,000 (366.38%) |
Depreciation Amortization & Accretion | $145,000 (-98.25%) | $8,291,000 (223.24%) | $2,565,000 (129.63%) | $1,117,000 (1430.14%) |
KLRS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -88.60% (11.13%) | -99.70% (-22.33%) | -81.50% (-33.39%) | -61.10% (-30.28%) |
Return on Average Assets (ROAA) | -58.20% (26.24%) | -78.90% (-17.06%) | -67.40% (-25.51%) | -53.70% (-94.57%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -225.60% (-39.95%) | -161.20% (-46.55%) | -110.00% (31.80%) | -161.30% (-246.88%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.82 (-122.10%) | -0.37 (84.09%) | -2.33 (50.62%) | -4.72 (68.18%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | -0.5 (-194.36%) | 0.53 (-75.01%) | 2.13 (-43.11%) | 3.74 (-47.21%) |
Debt to Equity Ratio (D/E) | -0.59 (-290.29%) | 0.31 (32.05%) | 0.23 (-13.97%) | 0.27 (444.00%) |
Earnings Per Share (EPS) | -11.73 (72.13%) | -42.09 (16.82%) | -50.6 (19.71%) | -63.02 (-5.79%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -13.52 (50.86%) | -27.51 (35.46%) | -42.62 (-9.40%) | -38.96 (25.37%) |
Book Value Per Share (BVPS) | -19.29 (-159.87%) | 32.22 (-52.17%) | 67.37 (-18.37%) | 82.53 (-72.67%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.23 (-97.08%) | 42.17 (-49.27%) | 83.14 (-20.82%) | 104.99 (-66.89%) |
Enterprise Value Over EBIT (EV/EBIT) | 1 (0%) | 0 (0%) | -2 (50.00%) | -4 (88.24%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 1.17 (1614.29%) | -0.08 (96.58%) | -2.25 (39.29%) | -3.71 (89.08%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 0.1 (-98.41%) | 6.62 (-33.76%) | 9.99 (49.22%) | 6.69 (-77.23%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$67,705,000 (45.60%) | -$124,451,000 (12.39%) | -$142,052,000 (-33.58%) | -$106,345,000 (-74.20%) |
Enterprise Value (EV) | -$68,330,649 (-589.85%) | $13,949,256 (-96.28%) | $374,910,990 (-40.51%) | $630,233,353 (-73.41%) |
Earnings Before Tax (EBT) | -$58,769,000 (69.16%) | -$190,544,000 (-12.76%) | -$168,975,000 (1.16%) | -$170,955,000 (-144.98%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$58,624,000 (67.83%) | -$182,253,000 (-9.52%) | -$166,410,000 (2.02%) | -$169,838,000 (-143.63%) |
Invested Capital | -$639,000 (-100.65%) | $98,885,000 (-45.42%) | $181,184,000 (137.48%) | $76,294,000 (-68.80%) |
Working Capital | -$22,097,000 (-113.87%) | $159,268,000 (-27.18%) | $218,714,000 (1.49%) | $215,495,000 (-38.26%) |
Tangible Asset Value | $6,162,000 (-96.77%) | $190,796,000 (-31.14%) | $277,079,000 (-3.32%) | $286,594,000 (-22.71%) |
Market Capitalization | $48,525,351 (-37.42%) | $77,540,256 (-83.78%) | $477,925,990 (-43.30%) | $842,922,353 (-66.32%) |
Average Equity | $66,308,500 (-65.27%) | $190,940,000 (-7.71%) | $206,889,250 (-26.47%) | $281,352,000 (88.94%) |
Average Assets | $100,955,500 (-58.19%) | $241,461,000 (-3.60%) | $250,465,500 (-21.85%) | $320,479,000 (26.79%) |
Invested Capital Average | $26,048,750 (-77.96%) | $118,180,000 (-23.09%) | $153,660,750 (45.03%) | $105,953,750 (-29.42%) |
Shares | 5,023,328 (1.29%) | 4,959,275 (22.43%) | 4,050,564 (43.02%) | 2,832,210 (0.05%) |
